Jinan, China

Jianjun Zhang

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Qilu Pharmaceutical Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jianjun Zhang. Retrieved from https://idiyas.com/inventor/jianjun-zhang-mlb78sg4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jianjun Zhang: Innovator in Pharmaceutical Composition

Introduction

Jianjun Zhang is a notable inventor based in Jinan, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions. His work is characterized by a focus on enhancing therapeutic efficacy through novel formulations.

Latest Patents

Jianjun Zhang holds a patent for a composition comprising aflibercept and a variant thereof, along with related methods and uses. This patent represents a significant advancement in the treatment options available for various medical conditions.

Career Highlights

Zhang is currently employed at Qilu Pharmaceutical Co., Ltd., a leading pharmaceutical company in China. His role at the company allows him to leverage his expertise in drug formulation and development, contributing to the advancement of healthcare solutions.

Collaborations

Throughout his career, Jianjun Zhang has collaborated with esteemed colleagues, including Huanlan Zheng and Guijiang Wang. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Jianjun Zhang's contributions to pharmaceutical innovations exemplify the impact of dedicated inventors in the healthcare industry. His work continues to pave the way for new therapeutic options and improved patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…